Skip to content

Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique

Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01472172
Enrollment
15
Registered
2011-11-16
Start date
2010-02-28
Completion date
2013-11-30
Last updated
2013-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pleural Diseases, Pleural Effusion

Keywords

Flex-rigid pleuroscopy, cryobiopsy, pleural biopsy, pleural effusion, safety, thoracoscopy

Brief summary

The purpose of this study is to determine feasibility of pleural biopsies with the cryoprobe during semirigid thoracoscopy. The secondary aim is to evaluate safety with focus on bleeding intensity.

Detailed description

The primary aim of this study is to determine feasibility of pleural biopsies with the cryoprobe during semirigid thoracoscopy. We will assess size, morphological features, immunohistochemistry and diagnostic yield as measures of the quality of the samples. The secondary aim is to evaluate safety with focus on bleeding intensity.

Interventions

DEVICECryobiopsy (Autoclavable cryoprobe 20416-032)

The tip of the cryoprobe will be attached to suspicious part of parietal pleura and activated by footswitch for 3 seconds. The frozen tissue is going to be extracted by gently pulling of the probe. The probe with the attached biopsy sample is going to be removed together with the thoracoscope through trocar. The biopsy sample will be released from the probe by thawing in the saline.

Sponsors

The University Clinic of Pulmonary and Allergic Diseases Golnik
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 or more years old * Unilateral pleural effusion of unknown origin * Pleural irregularities suspicious for pleural malignancy * Referral for thoracoscopy after less invasive means of diagnosis had failed

Exclusion criteria

* Uncontrolled bleeding tendency * Unstable cardiovascular status * Severe heart failure * ECOG performance status 4 * Persistent hypoxemia after evacuation of pleural fluid * Pleural symphisis, fibrothorax

Design outcomes

Primary

MeasureTime frameDescription
Number / percent of patients with useful pleural biopsy sample, obtained by cryoprobe12 monthsTo determine, wheather cryobiopsy specimen can be obtained in each patient
Size of biopsy samples12 monthsSize of the biopsy specimens in mm2
Quality of the sample12 monthsInterpretability of biopsy specimens in histopathology terms: 1. easily interpretable (enough tissue with all elements required for diagnosis) 2. interpretable with some difficulty (less tissue or diagnostic elements - diagnosis less reliable) 3. interpretable with great difficulty (little tissue or scarce diagnostic elements - low reliability of diagnosis) 4. non-interpretable (diagnosis not possible) Assessment of biopsy-related artifacts by describing the amount of unaltered tissue in quartiles

Secondary

MeasureTime frameDescription
Bleeding1 monthNumber of patients with a certain degree of bleeding from biopsy site, described as: 1 = slight, self-limited, 2 = moderate, requiring electrocautery intervention, 3 = severe, requiring interruption of the procedure, chest tube drainage and intravenous fluid resusucitation.

Countries

Slovenia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026